Italy probes Biogen for allegedly hindering sales of rival's MS drug Italy's antitrust authority (AGCM) said on Wednesday it had opened an investigation into Biogen Italia and its U.S. parent Biogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results